The Study of Cardiovascular Outcomes in Women With Preeclampsia Using Echocardiography: The SCOPE Study
Completed
Conditions studied: Preeclampsia
In brief
This study will evaluate the differences in cardiovascular parameters between women with severe preterm preeclampsia and those without preeclampsia using echocardiography and maternal blood. The investigators will also look at associations of abnormal cardiovascular findings and immediate complications among a high risk cohort of pregnant African American women.
Key facts
- Study ID
- NCT02357667
- Run by
- University of Pennsylvania
- People needed
- 192
- Starts
- 2015-03-01
- Expected to finish
- 2017-04-20
- Last updated by the study team
- 2018-05-02
Who can join
Age: 18 and older, up to 45. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- African American women who are admitted to the obstetrical unit with a concern for severe preeclampsia. Patients must be preterm (23-36 6/7 weeks) with a live singleton gestation and at least 18 years old. Women will baseline chronic hypertension and women on magnesium will be included.
You may not qualify if…
- Non-African American women, and African women with concern for severe preeclampsia who are admitted 23 weeks or 37 weeks. Women in labor will be excluded. Women with preexisting cardiovascular disease and women who are current smokers will be excluded.
- Unexposed controls:
- Inclusion Criteria:
- African American women obtaining prenatal care in our outpatient setting who meet matching criteria as noted above.
- Exclusion Criteria:
- Non-African American women and women who are not receiving care at our institution.
- All women who do not speak English and who are unable to be consented will be excluded.
Where it is running
- Hospital of the University of Pennsylvania — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.